DIN 02452421 — IRINOTECAN HYDROCHLORIDE INJECTION, USP 20 MG
IRINOTECAN HYDROCHLORIDE INJECTION, USP is a solution of Irinotecan marketed by GENERIC MEDICAL PARTNERS INC. The full Irinotecan monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02452421
- Brand name
- IRINOTECAN HYDROCHLORIDE INJECTION, USP
- Active ingredient
- Irinotecan
- Strength
- 20 MG
- Dosage form
- SOLUTION
- Route
- INTRAVENOUS
- Manufacturer
- GENERIC MEDICAL PARTNERS INC
- Health Canada status
- MARKETED
- Drug class
- Topoisomerase I inhibitor (antineoplastic agent)
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.
Other Irinotecan products
| DIN | Brand | Strength | Form | Manufacturer | Status |
|---|---|---|---|---|---|
| 02312409 | IRINOTECAN FOR INJECTION | 20 MG | SOLUTION | TEVA CANADA LIMITED | MARKETED |
| 02501279 | IRINOTECAN HYDROCHLORIDE INJECTION | 100 MG | SOLUTION | AURO PHARMA INC | MARKETED |
| 02528800 | IRINOTECAN HYDROCHLORIDE INJECTION | 100 MG | SOLUTION | EUGIA PHARMA INC. | MARKETED |
| 02501295 | IRINOTECAN HYDROCHLORIDE INJECTION | 500 MG | SOLUTION | AURO PHARMA INC | MARKETED |
| 02528789 | IRINOTECAN HYDROCHLORIDE INJECTION | 500 MG | SOLUTION | EUGIA PHARMA INC. | MARKETED |
| 02258218 | IRINOTECAN HYDROCHLORIDE INJECTION USP | 20 MG | SOLUTION | PFIZER CANADA ULC | MARKETED |
| 02357585 | IRINOTECAN HYDROCHLORIDE INJECTION USP | 20 MG | SOLUTION | ACCORD HEALTHCARE INC | MARKETED |
| 02345080 | IRINOTECAN HYDROCHLORIDE TRIHYDRATE FOR INJECTION | 20 MG | SOLUTION | FRESENIUS KABI CANADA LTD | DORMANT |